$LKFN

Raymond James reiterates Lakeland Financial stock rating after earnings beat

Raymond James maintained a Market Perform rating on Lakeland Financial (LKFN) after its Q3 earnings beat estimates, driven by higher net interest income and lower loss provisions. The company reported EPS of $1.14, above estimates, with strong loan growth and credit trends. Despite a premium valuation, InvestingPro suggests LKFN is undervalued with a PEG ratio of 0.73. The stock showed no significant movement after Q2 results, which included an earnings beat but revenue miss.

Original reporting
Published Oct 27, 2026, 6:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 6:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$LKFN
Bullish
medium confidence
Mentioned
$LKFN
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$LKFNBullishMed
01

Why it matters

Earnings beat and raised forecasts provide a fresh catalyst for price movement.

02

Market read

The earnings surprise and guidance lift make LKFN a potential short-term buying opportunity.

03

What to watch

Higher operating expenses and lower fee revenue could pressure margins going forward.

Relevance 7/10Novelty 7/10Timing: after-hours today

Background

Lakeland Financial reported Q3 results with EPS beat and modest revenue miss; rating reiterated.

Company-level read

Ticker impact

$LKFNBullishMedium confidence
Context

Q3 earnings beat estimates and EPS forecast raised; Raymond James reiterates Market Perform rating.

Expected impact

likely upward pressure as investors price in the earnings beat and higher forecasts

Evidence & confidence

The beat on EPS and raised guidance are fresh data that can attract buying interest.

Market effects

Positive earnings may lift the regional banking sector sentiment.

May boost investor confidence in U.S. community banks.

Limited to U.S. small-cap banking niche.

Counterpoint

If revenue shortfall concerns persist, the stock could face downside despite the EPS beat.

Key entities

  • Lakeland Financial

    U.S. regional bank reporting Q3 earnings.

  • Raymond James

    Reiterated Market Perform rating on LKFN.

Related articles

$LKFNHigh

Lakeland Financial Reports Record Third Quarter Performance with Loan Growth of 8%; Diluted Earnings per Share Increases by 11%

LAKELAND FINANCIAL CORP (LKFN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEWS FROM LAKELAND FINANCIAL CORPORATION FOR IMMEDIATE RELEASE Contact Lisa M. O’Neill Executive Vice President and Chief Financial Officer (574) 267-9125 lisa.oneill@lakecitybank.com Lakeland Financial Reports Record Third Quarter Performance with Loan Growth of 8%;

$LKFNMed

LAKELAND FINANCIAL CORP (LKFN): Results of Operations and Financial Condition

LAKELAND FINANCIAL CORP (LKFN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 lkfn-20260727exhibit991.htm EX-99.1 Document Exhibit 99.1 NEWS FROM LAKELAND FINANCIAL CORPORATION FOR IMMEDIATE RELEASE Contact Lisa M. O’Neill Executive Vice President and Chief Financial Officer (574) 267-9125 lisa.oneill@lakecitybank.com Lakeland Financial Reports R

$DINOHigh

Raymond James cuts HF Sinclair stock price target on valuation

Raymond James reduced HF Sinclair's (DINO) price target to $150 from $160, citing shifting macro conditions, but maintained a Strong Buy rating. The stock is down 9% weekly but up 154% year-to-date. The firm expects continued earnings growth and sees value in the company's diversified businesses. HF Sinclair reported Q3 2026 adjusted EPS of $11.75, beating estimates, with strong revenue and net income. The company's P/E ratio is 11.8, suggesting undervaluation.

$SIFYMed

SIFY TECHNOLOGIES LTD (SIFY): Financial results for Q2 2026

SIFY TECHNOLOGIES LTD (SIFY) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 For immediate release Chennai, India DETAILS OF EARNING CALL October 28, 2026| 8:30 AM ET | 06:00 PM IST Participant Dial in: To join: +1- 877-545-0320 (Toll Free in the U.S. or Canada) or +1-973-528-0002 (International) | Access Code: 656813 On the call: Mr. Raju Ve

$GMABHighAI 8/10

Biotech Stocks Rise: GMAB Surges, LUNG And AXGN Gain Over 30%

Genmab (GMAB) shares rose 33% after reporting positive Phase 3 results for its cancer drug. Pulmonx (LUNG) and Axogen (AXGN) shares gained over 30% on strong quarterly results. OrthoPediatrics (KIDS) and Replimune (REPL) also reported improved financials, driving their stock prices up. Specific financial data and guidance were provided by each company.